LEVETIRACETAM CIPLA

Main information

  • Trade name:
  • LEVETIRACETAM CIPLA Film-coated tablet 750MG
  • Dosage:
  • 750MG
  • Pharmaceutical form:
  • Film-coated tablet
  • Administration route:
  • Oral use
  • Units in package:
  • 10 Blister
  • Prescription type:
  • on prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LEVETIRACETAM CIPLA Film-coated tablet 750MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Levetiracetam
  • Product summary:
  • TBL FLM 10X750MG

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 21/ 099/15-C
  • Last update:
  • 24-11-2016

26-11-2018

Levetiracetam Hospira (Pfizer Europe MA EEIG)

Levetiracetam Hospira (Pfizer Europe MA EEIG)

Levetiracetam Hospira (Active substance: levetiracetam) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)7985 of Mon, 26 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2783/T/19

Europe -DG Health and Food Safety

22-11-2018

Levetiracetam Hospira (Hospira UK Limited)

Levetiracetam Hospira (Hospira UK Limited)

Levetiracetam Hospira (Active substance: levetiracetam) - Centralised - Renewal - Commission Decision (2018)7895 of Thu, 22 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2783/R/18

Europe -DG Health and Food Safety